Systemic treatments for metastatic cutaneous melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic treatments for metastatic cutaneous melanoma

Published:2018-02-06 Issue:11 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pasquali Sandro¹,Hadjinicolaou Andreas V²,Chiarion Sileni Vanna³,Rossi Carlo Riccardo⁴,Mocellin Simone⁵⁶

Affiliation:

1. Sarcoma Service; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

2. Human Immunology Unit, Institute of Molecular Medicine, Radcliffe Department of Medicine; University of Oxford; Oxford UK

3. Medical Oncology Unit 2; Istituto Oncologico Veneto, IOV-IRCCS; Padova Italy

4. Melanoma and Sarcomas Unit; Istituto Oncologico Veneto, IOV-IRCCS; Padova Italy

5. Surgical Oncology Unit; Istituto Oncologico Veneto, IOV-IRCCS; Padova Italy

6. Istituto Oncologico Veneto; IOV-IRCCS; Padova Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Reference281 articles.

1. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma;Agarwala;Cancer,1999

2. Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma;Agarwala;Journal of Clinical Oncology,2002

3. Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group;Atkins;Journal of Clinical Oncology,2008

4. Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM);Atzpodien;British Journal of Cancer,2002

5. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study;Avril;Journal of Clinical Oncology,2004

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing of Antidiarrheal Loperamide for Treating Melanoma by Inducing Cell Apoptosis and Cell Metastasis Suppression In vitro and In vivo;Current Cancer Drug Targets;2024-10

2. Melanoma in a Colombian population: a survival study;Melanoma Management;2024-08-05

3. Cuproptosis-related DNA methylation signature predict prognosis and immune microenvironment in cutaneous melanoma;Discover Oncology;2024-06-14

4. Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational Therapeutics;Drug Safety;2024-04-30

5. Isolated Limb Perfusion for Extremity Soft Tissue Sarcoma and Malignant Melanoma;Indian Journal of Surgical Oncology;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3